Your browser doesn't support javascript.
loading
Fluoroquinolone resistance does not impose a cost on the fitness of Clostridium difficile in vitro.
Wasels, François; Kuehne, Sarah A; Cartman, Stephen T; Spigaglia, Patrizia; Barbanti, Fabrizio; Minton, Nigel P; Mastrantonio, Paola.
Afiliação
  • Wasels F; Department of Infectious, Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanità, Rome, Italy.
  • Kuehne SA; Clostridia Research Group, Centre for Biomolecular Sciences, School of Life Sciences, Nottingham Digestive Diseases Centre, NIHR Biomedical Research Unit, The University of Nottingham, University Park, Nottingham, United Kingdom.
  • Cartman ST; Clostridia Research Group, Centre for Biomolecular Sciences, School of Life Sciences, Nottingham Digestive Diseases Centre, NIHR Biomedical Research Unit, The University of Nottingham, University Park, Nottingham, United Kingdom.
  • Spigaglia P; Department of Infectious, Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanità, Rome, Italy patrizia.spigaglia@iss.it.
  • Barbanti F; Department of Infectious, Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanità, Rome, Italy.
  • Minton NP; Clostridia Research Group, Centre for Biomolecular Sciences, School of Life Sciences, Nottingham Digestive Diseases Centre, NIHR Biomedical Research Unit, The University of Nottingham, University Park, Nottingham, United Kingdom.
  • Mastrantonio P; Department of Infectious, Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanità, Rome, Italy.
Antimicrob Agents Chemother ; 59(3): 1794-6, 2015 Mar.
Article em En | MEDLINE | ID: mdl-25534738
ABSTRACT
Point mutations conferring resistance to fluoroquinolones were introduced in the gyr genes of the reference strain Clostridium difficile 630. Only mutants with the substitution Thr-82→Ile in GyrA, which characterizes the hypervirulent epidemic clone III/027/NAP1, were resistant to all fluoroquinolones tested. The absence of a fitness cost in vitro for the most frequent mutations detected in resistant clinical isolates suggests that resistance will be maintained even in the absence of antibiotic pressure.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Clostridioides difficile / Fluoroquinolonas / Farmacorresistência Bacteriana Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Clostridioides difficile / Fluoroquinolonas / Farmacorresistência Bacteriana Idioma: En Ano de publicação: 2015 Tipo de documento: Article